- Category
- Micro (2021-22)
- Udyam number
- UDYAM-HP-04-0004645

About Cell Cross Pharmaceuticals Private Limited
Data last updated:
Cell Cross Pharmaceuticals Private Limited is a private limited company based in Kangra, Himachal Pradesh, India. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 08 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U33119HP2021PTC008805.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Monika and Manju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Aprajit Kumar Vpo Lag Badhna Tehsil Dehra, Kangra, Himachal Pradesh, India – 177107.
As per the financials filed for FY 2025, the company reported a revenue of ₹88.89 Lakh, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹64,104 (net margin 0.7%) and EBITDA of ₹1.13 Lakh (EBITDA margin 1.3%).
The company is associated with 1 brand: Cell Cross.
Cell Cross Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-04-0004645). For more details, the company can be reached via its website cellcross.in.
Company details
Recognitions & Rankings of Cell Cross Pharmaceuticals
Contact details
Cell Cross Pharmaceuticals Private Limited's registered office is in Kangra, Himachal Pradesh.
- Social Media
- Registered AddressC/O Aprajit Kumar Vpo Lag Badhna Tehsil Dehra, Kangra, Himachal Pradesh, India – 177107
- IndustryHealthcare, Manufacturing, Other Medical And Surgical Equipment, Medical & Surgical Equipment, Orthopedic Appliances, Medical Appliances And Instruments
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cell Cross Pharmaceuticals operates one associated brand: Cell Cross. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical marketing and innovation services in India. | cellcross.in |
Business activity
The main business activity of Cell Cross Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cell Cross Pharmaceuticals Private Limited, buy the company report.
Financials of Cell Cross Pharmaceuticals Private Limited
FY 2025 filings availableCell Cross Pharmaceuticals Private Limited reported revenue of ₹88.89 Lakh (up 54% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 54% in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.13 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹64,104 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.3% | |||
| Net Profit Margin | 0.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Cell Cross Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cell Cross Pharmaceuticals Private Limited
Cell Cross Pharmaceuticals has 2 directors on record. No former directors are listed.
Peer comparison
Cell Cross Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aph Pharmaceuticals Private Limited | ₹89.53 Lakh (FY 2022) | -16.0% | Noida, Uttar Pradesh, India | |||
| Claribel Pharmaceuticals Private Limited | ₹88.92 Lakh (FY 2025) | 29.0% | Hyderabad, Telangana, India | |||
| Cell Cross Pharmaceuticals Private Limitedthis company | ₹88.89 Lakh (FY 2025) | ₹64,104 | 0.7% | 54.0% | Kangra, Himachal Pradesh, India | |
| GDF Pharmaceuticals Private Limited | ₹88.68 Lakh (FY 2025) | 11.0% | Gorakhpur, Uttar Pradesh, India | |||
| Vrisan Pharmaceuticals Private Limited | ₹88.49 Lakh (FY 2024) | 146.0% | Ward-Fazullaganj, Uttar Pradesh, India | |||
| Nuclomed Pharmaceuticals Private Limited | ₹88.43 Lakh (FY 2024) | -3.0% | Moradabad, Uttar Pradesh, India |
To see the full peer comparison of Cell Cross Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cell Cross Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cell Cross Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cell Cross Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cell Cross Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Manju was appointed as Director on 08 Sep 2021.
Frequently asked questions
Cell Cross Pharmaceuticals is an active private limited company based in Kangra, Himachal Pradesh, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 08 September 2021 (5+ years old) and is registered under CIN U33119HP2021PTC008805.
The latest financial statements of Cell Cross Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Cell Cross Pharmaceuticals is U33119HP2021PTC008805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cell Cross Pharmaceuticals was incorporated on 08 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Cell Cross Pharmaceuticals by revenue are Aph Pharmaceuticals Private Limited, Claribel Pharmaceuticals Private Limited, GDF Pharmaceuticals Private Limited, Vrisan Pharmaceuticals Private Limited, Nuclomed Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Manju was appointed as Director on 08 Sep 2021. Monika was appointed as Director on 08 Sep 2021.
Yes, Cell Cross Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HP-04-0004645).
Cell Cross Pharmaceuticals can be reached through the website cellcross.in. Its registered office is in Kangra, Himachal Pradesh, India.
The registered office of Cell Cross Pharmaceuticals is at CO Aprajit Kumar Vpo Lag Badhna Tehsil Dehra, Kangra, Himachal Pradesh, India – 177107.
Cell Cross Pharmaceuticals operates in the healthcare industry, in the manufacturing segment.

